Alexandra Apalaghiei, a 35‑year‑old mother liivng in London, was confirmed to have amyotrophic lateral sclerosis (ALS) in April 2023 after months of testing. The progressive disease now threatens her ability to walk and speak, forcing her to rely on her partner for daily care .

April 2023 Neurologist Confirmation of ALS

According to the Daily Mail report, a neurologist finally diagnosed Ms . Apalaghiei with ALS in April 2023 following an electromyography (EMG) and nerve conduction study (NCS) conducted in December 2022. the specialist explained the typical disease trajectory, noting that only about 20 % of ALS patients survive beyond five years.

Early Symptoms Trace Back to November 2021

Ms. Apalaghiei believes the first signs appeared in November 2021, when she woke each morning with “extreme stiffness” that worsened after a fall in January 2022. By February, her left arm felt unusually heavy, prompting a GP visit that initially attributed the pain to the injury.

Financial Strain Sparks GoFundMe Campaign

Since losing her job at a five‑star hotel, the family faces mounting medical bills and equipment costs. Relatives have opened a GoFundMe page to cover treatments, a walking frame, and home‑care support, urging donors to help “focus on what matters most.” The fundraiser aims to provide a safety net while Ms. Apalaghiei spends time with her son.

Living with a Walking Frame and Wheelchair

Ms. Apalaghiei now uses a walking frame at home and a wheelchair for outings, describing each step as a balance challenge. She has installed handrails, shower grips,and specialised cutlery to adapt to a “new normal,” and remains determined to keep using her legs as long as possible, citing research that exercise can improve quality of life.

Who Remains Uncertain About Long‑Term Outlook?

The report does not reveal whether Ms. Apalaghiei has accessed experimental therapies or clinical trials, leaving open questions about potential extensions to her life expectancy and the availability of specialist ALS care in the UK.